Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

NK Cell Reconstitution in Paediatric Leukemic Patients after T-Cell-Depleted HLA-Haploidentical Haematopoietic Stem Cell Transplantation Followed by the Reinfusion of iCasp9-Modified Donor T Cells.

Stabile H, Nisti P, Fionda C, Pagliara D, Gaspari S, Locatelli F, Santoni A, Gismondi A.

J Clin Med. 2019 Nov 7;8(11). pii: E1904. doi: 10.3390/jcm8111904.

2.

The POU-Domain Transcription Factor Oct-6/POU3F1 as a Regulator of Cellular Response to Genotoxic Stress.

Fionda C, Di Bona D, Kosta A, Stabile H, Santoni A, Cippitelli M.

Cancers (Basel). 2019 Jun 11;11(6). pii: E810. doi: 10.3390/cancers11060810.

3.

Negative regulation of innate lymphoid cell responses in inflammation and cancer.

Sciumè G, Fionda C, Stabile H, Gismondi A, Santoni A.

Immunol Lett. 2019 Nov;215:28-34. doi: 10.1016/j.imlet.2019.01.011. Epub 2019 Jan 31.

PMID:
30711614
4.

Key Role of the CD56lowCD16low Natural Killer Cell Subset in the Recognition and Killing of Multiple Myeloma Cells.

Vulpis E, Stabile H, Soriani A, Fionda C, Petrucci MT, Mariggio' E, Ricciardi MR, Cippitelli M, Gismondi A, Santoni A, Zingoni A.

Cancers (Basel). 2018 Nov 29;10(12). pii: E473. doi: 10.3390/cancers10120473.

5.

Translating the anti-myeloma activity of Natural Killer cells into clinical application.

Fionda C, Stabile H, Molfetta R, Soriani A, Bernardini G, Zingoni A, Gismondi A, Paolini R, Cippitelli M, Santoni A.

Cancer Treat Rev. 2018 Nov;70:255-264. doi: 10.1016/j.ctrv.2018.10.005. Epub 2018 Oct 10. Review.

PMID:
30326421
6.

JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians.

Stabile H, Scarno G, Fionda C, Gismondi A, Santoni A, Gadina M, Sciumè G.

Immunol Rev. 2018 Nov;286(1):148-159. doi: 10.1111/imr.12705. Review.

7.

Impact of bone marrow-derived signals on NK cell development and functional maturation.

Stabile H, Fionda C, Santoni A, Gismondi A.

Cytokine Growth Factor Rev. 2018 Aug;42:13-19. doi: 10.1016/j.cytogfr.2018.03.008. Epub 2018 Mar 27. Review.

PMID:
29622473
8.

Chemokine regulation of innate lymphoid cell tissue distribution and function.

Soriani A, Stabile H, Gismondi A, Santoni A, Bernardini G.

Cytokine Growth Factor Rev. 2018 Aug;42:47-55. doi: 10.1016/j.cytogfr.2018.02.003. Epub 2018 Feb 14. Review.

PMID:
29472011
10.

Innate immune activating ligand SUMOylation affects tumor cell recognition by NK cells.

Zitti B, Molfetta R, Fionda C, Quatrini L, Stabile H, Lecce M, de Turris V, Ricciardi MR, Petrucci MT, Cippitelli M, Gismondi A, Santoni A, Paolini R.

Sci Rep. 2017 Sep 5;7(1):10445. doi: 10.1038/s41598-017-10403-0.

11.

Leukocyte trafficking in tumor microenvironment.

Del Prete A, Schioppa T, Tiberio L, Stabile H, Sozzani S.

Curr Opin Pharmacol. 2017 Aug;35:40-47. doi: 10.1016/j.coph.2017.05.004. Epub 2017 May 31. Review.

PMID:
28577499
12.

Role of Distinct Natural Killer Cell Subsets in Anticancer Response.

Stabile H, Fionda C, Gismondi A, Santoni A.

Front Immunol. 2017 Mar 16;8:293. doi: 10.3389/fimmu.2017.00293. eCollection 2017. Review.

13.

High expression levels of IP10/CXCL10 are associated with modulation of the natural killer cell compartment in multiple myeloma.

Bernardini G, Vulpis E, Bonanni V, Stabile H, Ricciardi MR, Petrucci MT, Gismondi A, Santoni A, Zingoni A.

Leuk Lymphoma. 2017 Oct;58(10):2493-2496. doi: 10.1080/10428194.2017.1295144. Epub 2017 Feb 28. No abstract available.

PMID:
28278706
14.

Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS.

Franzese O, Palermo B, Di Donna C, Sperduti I, Ferraresi V, Stabile H, Gismondi A, Santoni A, Nisticò P.

Oncoimmunology. 2016 Feb 1;5(5):e1114203. doi: 10.1080/2162402X.2015.1114203. eCollection 2016 May.

15.

Effector Functions of Natural Killer Cell Subsets in the Control of Hematological Malignancies.

Gismondi A, Stabile H, Nisti P, Santoni A.

Front Immunol. 2015 Nov 5;6:567. doi: 10.3389/fimmu.2015.00567. eCollection 2015. Review.

16.

Response to comment on Multifunctional human CD56low CD16low NK cells are the prominent subset in bone marrow of both pediatric healthy donors and leukemic patients.

Stabile H, Nisti P, Pagliara D, Locatelli F, Santoni A, Gismondi A.

Haematologica. 2015 Aug;100(8):e332-3. doi: 10.3324/haematol.2015.130831. No abstract available.

17.

In Vivo Imaging of Natural Killer Cell Trafficking in Tumors.

Galli F, Rapisarda AS, Stabile H, Malviya G, Manni I, Bonanno E, Piaggio G, Gismondi A, Santoni A, Signore A.

J Nucl Med. 2015 Oct;56(10):1575-80. doi: 10.2967/jnumed.114.152918. Epub 2015 Aug 13.

18.

Multifunctional human CD56 low CD16 low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients.

Stabile H, Nisti P, Morrone S, Pagliara D, Bertaina A, Locatelli F, Santoni A, Gismondi A.

Haematologica. 2015 Apr;100(4):489-98. doi: 10.3324/haematol.2014.116053. Epub 2015 Jan 16.

19.

Chemerin regulates NK cell accumulation and endothelial cell morphogenesis in the decidua during early pregnancy.

Carlino C, Trotta E, Stabile H, Morrone S, Bulla R, Soriani A, Iannitto ML, Agostinis C, Mocci C, Minozzi M, Aragona C, Perniola G, Tedesco F, Sozzani S, Santoni A, Gismondi A.

J Clin Endocrinol Metab. 2012 Oct;97(10):3603-12. doi: 10.1210/jc.2012-1102. Epub 2012 Jul 12.

20.

An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development.

Agostinis C, Bulla R, Tripodo C, Gismondi A, Stabile H, Bossi F, Guarnotta C, Garlanda C, De Seta F, Spessotto P, Santoni A, Ghebrehiwet B, Girardi G, Tedesco F.

J Immunol. 2010 Oct 1;185(7):4420-9. doi: 10.4049/jimmunol.0903215. Epub 2010 Sep 1.

Supplemental Content

Loading ...
Support Center